Doris Andert

Title: **The Innovations of Doris Andert: A Pioneer in Pharmaceutical Formulations**

Introduction

Doris Andert, based in Frankfurt am Main, Germany, is a talented inventor renowned for her contributions to the field of pharmaceuticals. With a focus on innovative formulations, she has successfully secured a patent that highlights her expertise and dedication to advancing medical treatments.

Latest Patents

Doris Andert holds a significant patent concerning "Otamixaban formulations with improved stability." This invention encompasses a pharmaceutical composition that includes methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate, or a pharmaceutically acceptable salt thereof. The patent also covers a pharmaceutically acceptable acidic reacting compound or an aqueous solution or dispersion of the composition. Furthermore, it outlines a process for preparing the composition and methods of utilizing it to treat conditions manageable by the administration of an inhibitor of Factor Xa.

Career Highlights

Doris currently works at Sanofi, a prominent global healthcare company dedicated to transforming scientific innovations into advances in health. Her role at Sanofi allows her to be at the forefront of pharmaceutical development, wherein she utilizes her skills to innovate new solutions for treating various medical conditions.

Collaborations

Throughout her career, Doris has collaborated with notable professionals such as Walter Kamm and Till Bussemer. These partnerships reflect the power of teamwork in advancing scientific research and developing cutting-edge pharmaceutical products.

Conclusion

Doris Andert's contributions to the pharmaceutical industry through her innovative discoveries exemplify the vital role inventors play in enhancing healthcare solutions. Her patent for Otamixaban formulations demonstrates her commitment to creating effective treatments, benefitting countless patients worldwide. Doris's work not only embodies personal achievement but also signifies the collaborative spirit that drives progress in the field of medical research.